October 13, 2022
Top False Claims Act Developments
May 25, 2021
Stats Without Facts: Another Court Rejects Data Mining Qui Tam Strategy
September 24, 2018
Echoes of the Brand Memo
January 31, 2018
The Brand Memorandum: DOJ Restricts Reliance on Agency Guidance in Civil Enforcement Actions
January 26, 2017
FDA Defends Its First Amendment Position in “Memorandum”
January 19, 2017
FDA Takes Action in the Last Days of the Obama Administration to Clarify Some of Its Views on Off-Label Communications
November 1, 2016
FDA Launches Form for Reporting Allegations of Misconduct by Device Manufacturers
June 20, 2016
Universal Health Services v. Escobar
April 29, 2016
The US v. Vascular Solutions Acquittal: Three Lessons for Targets of "Off-Label Promotion" Enforcement
April 19, 2016
Settle or Fight FDA/DOJ Off-Label Use Allegations? WSJ Editorial Looks at Vascular Solutions Trial Win and Asks What's Next?
March 9, 2016
Amarin and FDA Reach Settlement Agreement in Off-Label Speech/First Amendment Case
November 12, 2015
Establishing the Application of The Foreign Sovereign Immunities Act’s Arbitration Exception